Who are Natrium picosulfate / Magnesium citrate's main competitors?

No direct comparators detected in our index.

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/natrium-picosulfate-magnesium-citrate.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-05-18 · How we verify

Natrium picosulfate / Magnesium citrate — Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Natrium picosulfate / Magnesium citrate (Natrium picosulfate / Magnesium citrate) competitive landscape: 0 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Stimulant laxative / osmotic laxative combination. Area: Gastroenterology.

marketed Stimulant laxative / osmotic laxative combination Gastroenterology Small molecule Live · refreshed every 30 min

Target snapshot

Natrium picosulfate / Magnesium citrate (Natrium picosulfate / Magnesium citrate) — Tomas Bata Hospital, Czech Republic. Sodium picosulfate is a prodrug that is converted by colonic bacteria to bis-(p-hydroxyphenyl)-pyridyl-methane, which stimulates colonic contractions, while magnesium citrate acts as an osmotic laxative to retain water in the intestinal lumen.

Comparator set

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class	Target	Approval / PDUFA
Natrium picosulfate / Magnesium citrate TARGET	Natrium picosulfate / Magnesium citrate	Tomas Bata Hospital, Czech Republic	marketed	Stimulant laxative / osmotic laxative combination

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Stimulant laxative / osmotic laxative combination class)

Tomas Bata Hospital, Czech Republic · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Natrium picosulfate / Magnesium citrate — Competitive Intelligence Brief. https://druglandscape.com/ci/natrium-picosulfate-magnesium-citrate. Accessed 2026-05-18.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab